SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jayne Smith-Palmer, Karin Cerri, William Valentine, Achieving sustained virologic response in hepatitis C: a systematic review of the clinical, economic and quality of life benefits, BMC Infectious Diseases, 2015, 15, 1, 19

    CrossRef

  2. 2
    Akihiro Tamori, Yoshiki Murakami, Shoji Kubo, Saori Itami, Sawako Uchida-Kobayashi, Hiroyasu Morikawa, Masaru Enomoto, Shigekazu Takemura, Toshihito Tanahashi, Y-h. Taguchi, Norifumi Kawada, MicroRNA expression in hepatocellular carcinoma after the eradication of chronic hepatitis virus C infection using interferon therapy, Hepatology Research, 2015, 45, 8
  3. 3
    Fabio Salvatore Macaluso, Vincenza Calvaruso, Antonio Craxì, Residual risk of hepatocellular carcinoma after HCV eradication: more than meets the eye, Future Microbiology, 2015, 10, 6, 977

    CrossRef

  4. 4
    Yasuharu Imai, Jun-ichi Taira, Mayumi Okada, Mayumi Ando, Takatomo Sano, Yuhki Miyata, Katsutoshi Sugimoto, Ikuo Nakamura, Fuminori Moriyasu, The close linkage between the elasticity modulus measured by real-time mapping shear wave elastography and the presence of hepatocellular carcinoma in patients with a sustained virological response to interferon for chronic hepatitis C, Journal of Medical Ultrasonics, 2015, 42, 3, 341

    CrossRef

  5. 5
    Naoki Yamashita, Aritsune Ohho, Akihiro Yamasaki, Miho Kurokawa, Kazuhiro Kotoh, Eiji Kajiwara, Hepatocarcinogenesis in chronic hepatitis C patients achieving a sustained virological response to interferon: significance of lifelong periodic cancer screening for improving outcomes, Journal of Gastroenterology, 2014, 49, 11, 1504

    CrossRef

  6. 6
    Koichi Matsuzaki, Toshihito Seki, Kazuichi Okazaki, TGF-β signal shifting between tumor suppression and fibro-carcinogenesis in human chronic liver diseases, Journal of Gastroenterology, 2014, 49, 6, 971

    CrossRef

  7. 7
    Takashi Yamaguchi, Koichi Matsuzaki, Ryosuke Inokuchi, Rinako Kawamura, Katsunori Yoshida, Miki Murata, Junichi Fujisawa, Nobuyoshi Fukushima, Michio Sata, Masayoshi Kage, Osamu Nakashima, Akihiro Tamori, Norifumi Kawada, Koichi Tsuneyama, Steven Dooley, Toshihito Seki, Kazuichi Okazaki, Phosphorylated Smad2 and Smad3 signaling: Shifting between tumor suppression and fibro-carcinogenesis in chronic hepatitis C, Hepatology Research, 2013, 43, 12
  8. 8
    Marc Bourlière, Asma Khaloun, Claire Wartelle-Bladou, Valérie Oules, Isabelle Portal, Souad Benali, Xavier Adhoute, Paul Castellani, Future treatment of patients with HCV cirrhosis, Liver International, 2012, 32,
  9. 9
    Sudeep Tanwar, Paul M. Trembling, Geoffrey M. Dusheiko, Hepatitis C Therapy: Lessons of the Last Two Decades, Current Hepatitis Reports, 2012, 11, 3, 119

    CrossRef

  10. 10
    Yoshimasa Hashimoto, Daisuke Miyaki, Eisuke Murakami, Yuko Nagaoki, Yuki Kimura, Azakami Takahiro, Yoshio Katamura, Tomokazu Kawaoka, Shintaro Takaki, Masataka Tsuge, Nobuhiko Hiraga, Akira Hiramatsu, Koji Waki, Michio Imamura, Hiroshi Aikata, Shoichi Takahashi, Koji Arihiro, Hideki Ohdan, Kazuaki Chayama, Multicentric hepatocarcinogenesis at 6 and 13 years after sustained viral response to hepatitis C virus, Clinical Journal of Gastroenterology, 2012, 5, 3, 204

    CrossRef

  11. 11
    Cristina Della Corte, Massimo Colombo, Surveillance for Hepatocellular Carcinoma, Seminars in Oncology, 2012, 39, 4, 384

    CrossRef

  12. 12
    Mark W. Russo, The Role of Interferon Therapy in Patients with Hepatocellular Carcinoma, Current Hepatitis Reports, 2012, 11, 4, 279

    CrossRef

  13. 13
    Roberta D’Ambrosio, Alessio Aghemo, Treatment of Patients With HCV Related Cirrhosis: Many Rewards With Very Few Risks, Hepatitis Monthly, 2012, 12, 6, 361

    CrossRef

  14. 14
    Norio Akuta, Fumitaka Suzuki, Miharu Hirakawa, Yusuke Kawamura, Hitomi Sezaki, Yoshiyuki Suzuki, Tetsuya Hosaka, Masahiro Kobayashi, Mariko Kobayashi, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda, Hiromitsu Kumada, Amino acid substitutions in hepatitis C virus core region predict hepatocarcinogenesis following eradication of HCV RNA by antiviral therapy, Journal of Medical Virology, 2011, 83, 6
  15. 15
    Vivian Ng, Sammy Saab, Effects of a Sustained Virologic Response on Outcomes of Patients With Chronic Hepatitis C, Clinical Gastroenterology and Hepatology, 2011, 9, 11, 923

    CrossRef

  16. 16
    José Velosa, Fátima Serejo, Rui Marinho, Joana Nunes, Helena Glória, Eradication of Hepatitis C Virus Reduces the Risk of Hepatocellular Carcinoma in Patients with Compensated Cirrhosis, Digestive Diseases and Sciences, 2011, 56, 6, 1853

    CrossRef

  17. 17
    Tram NQ Pham, Tomasz I Michalak, Occult Hepatitis C Virus Infection and Its Relevance in Clinical Practice, Journal of Clinical and Experimental Hepatology, 2011, 1, 3, 185

    CrossRef

  18. 18
    Scott R. Walter, Hla-Hla Thein, Janaki Amin, Heather F. Gidding, Kate Ward, Matthew G. Law, Jacob George, Gregory J. Dore, Trends in mortality after diagnosis of hepatitis B or C infection: 1992–2006, Journal of Hepatology, 2011, 54, 5, 879

    CrossRef

  19. 19
    Elena Vezali, Alessio Aghemo, Massimo Colombo, A review of the treatment of chronic hepatitis C virus infection in cirrhosis, Clinical Therapeutics, 2010, 32, 13, 2117

    CrossRef

  20. 20
    Nobuyoshi Fukushima, Ryoko Kuromatsu, Teruko Arinaga-Hino, Eiji Ando, Akio Takata, Shuji Sumie, Masahito Nakano, Takumi Kawaguchi, Tatsuya Ide, Takuji Torimura, Michio Sata, Adipocytokine involvement in hepatocellular carcinoma after sustained response to interferon for chronic hepatitis C, Hepatology Research, 2010, 40, 9
  21. 21
    Yalena Amador-Cañizares, Santiago Dueñas-Carrera, Early Interferon-Based Treatment After Detection of Persistent Hepatitis C Virus Infection: A Critical Decision, Journal of Interferon & Cytokine Research, 2010, 30, 11, 817

    CrossRef

  22. 22
    Sandro da Costa Ferreira, Marcos de Vasconcelos Carneiro, Fernanda Fernandes Souza, Andreza Corrêa Teixeira, Marcia Guimarães Villanova, José Fernando de Castro Figueiredo, Afonso Dinis Costa Passos, Leandra Naira Zambelli Ramalho, Sergio Zucoloto, Ana de Lourdes Candolo Martinelli, Long-term follow-up of patients with chronic hepatitis C with sustained virologic response to interferon, The Brazilian Journal of Infectious Diseases, 2010, 14, 4, 330

    CrossRef

  23. 23
    Kensaku Sanefuji, Hiroto Kayashima, Tomohiro Iguchi, Keishi Sugimachi, Yo-ichi Yamashita, Tomoharu Yoshizumi, Yuji Soejima, Takashi Nishizaki, Akinobu Taketomi, Yoshihiko Maehara, Characterization of hepatocellular carcinoma developed after achieving sustained virological response to interferon therapy for hepatitis C, Journal of Surgical Oncology, 2009, 99, 1
  24. 24
    Tsuyoshi Mashitani, Hitoshi Yoshiji, Masaharu Yamazaki, Yasuhide Ikenaka, Ryuichi Noguchi, Masatoshi Ishikawa, Hideto Kawaratani, Norihide Matsuo, Masahito Uemura, Junichi Yamao, Masao Fujimoto, Akira Mitoro, Masahisa Toyohara, Motoyuki Yoshida, Masayoshi Sawai, Chie Morioka, Tatsuhiro Tsujimoto, Mitsuteru Kitade, Kosuke Kaji, Yosuke Aihara, Hiroshi Fukui, Development of hepatocellular carcinoma in a patient 13 years after sustained virological response to interferon against chronic hepatitis C: a case report, Cases Journal, 2009, 2, 1, 18

    CrossRef

  25. You have free access to this content25
    Marc G. Ghany, Doris B. Strader, David L. Thomas, Leonard B. Seeff, Diagnosis, management, and treatment of hepatitis C: An update, Hepatology, 2009, 49, 4
  26. 26
    Mark W. Russo, Erratum to: The Role of Interferon Therapy in Patients With Hepatocellular Carcinoma, Current Hepatitis Reports, 2009, 8, S1, 35

    CrossRef

  27. 27
    Akihiro Tamori, Takehiro Hayashi, Mayumi Shinzaki, Sawako Kobayashi, Shuji Iwai, Masaru Enomoto, Hiroyasu Morikawa, Hiroki Sakaguchi, Susumu Shiomi, Shigekazu Takemura, Shoji Kubo, Norifumi Kawada, Frequent detection of hepatitis B virus DNA in hepatocellular carcinoma of patients with sustained virologic response for hepatitis C virus, Journal of Medical Virology, 2009, 81, 6
  28. 28
    Joseph Ahn, Steven L. Flamm, Hepatitis C and hepatocellular carcinoma: New developments in natural history and treatment, Current Hepatitis Reports, 2009, 8, 2, 59

    CrossRef

  29. 29
    Ayse L. Mindikoglu, Ram R. Miller, Hepatitis C in the Elderly: Epidemiology, Natural History, and Treatment, Clinical Gastroenterology and Hepatology, 2009, 7, 2, 128

    CrossRef

  30. 30
    Alajos Pár, Prophylaxis and treatment of chronic viral hepatitis as the prevention of hepatocellular carcinoma, Orvosi Hetilap, 2009, 150, 1, 19

    CrossRef

  31. 31
    Bruce R. Bacon, Mitchell L. Shiffman, Flavia Mendes, Reem Ghalib, Tarek Hassanein, Giuseppe Morelli, Shobha Joshi, Kenneth Rothstein, Paul Kwo, Norman Gitlin, Retreating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: DIRECT results, Hepatology, 2009, 49, 6
  32. 32
    Maria Pleguezuelo, Laura Marelli, Sergio Maimone, Pinelopi Manousou, Elias Xirouchakis, Andrew K. Burroughs, Does HCV antiviral therapy decrease the risk of hepatocellular carcinoma?, Current Hepatitis Reports, 2008, 7, 2, 72

    CrossRef

  33. 33
    Francesca Cainelli, Hepatitis C Virus Infection in the Elderly, Drugs & Aging, 2008, 25, 1, 9

    CrossRef

  34. 34
    Miharu Hirakawa, Kenji Ikeda, Yasuji Arase, Yusuke Kawamura, Hiromi Yatsuji, Tetsuya Hosaka, Hitomi Sezaki, Norio Akuta, Masahiro Kobayashi, Satoshi Saitoh, Fumitaka Suzuki, Yoshiyuki Suzuki, Hiromitsu Kumada, Hepatocarcinogenesis Following HCV RNA Eradication by Interferon in Chronic Hepatitis Patients, Internal Medicine, 2008, 47, 19, 1637

    CrossRef

  35. 35
    T.-M. Scherzer, K. R. Reddy, F. Wrba, H. Hofer, K. Staufer, P. Steindl-Munda, A. Gangl, P. Ferenci, Hepatocellular carcinoma in long-term sustained virological responders following antiviral combination therapy for chronic hepatitis C, Journal of Viral Hepatitis, 2008, 15, 9